Gene variants may explain why some breast cancer patients skip their medications

A new study links a common genetic variation to poor adherence with endocrine therapy in early breast cancer patients. The finding suggests genetic testing could identify patients at risk of abandoning treatment, potentially improving survival rates and reducing healthcare costs from disease recurrence.

Originaltitel: Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records